Alpha Omega Wealth Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Alpha Omega Wealth Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-140	Closed	-$11K	–	579
2019 Q2	$11K	Hold	140	–	–	﹤0.01%	435
2019 Q1	$16K	Hold	140	–	–	0.01%	379
2018 Q4	$14K	Hold	140	–	–	0.01%	338
2018 Q3	$18K	Hold	140	–	–	0.01%	327
2018 Q2	$12K	Hold	140	–	–	0.01%	367
2018 Q1	$9K	Buy	140 +80	+133%	+$4.82K	﹤0.01%	359
2017 Q4	$4K	Sell	60 -56	-48%	-$3.53K	﹤0.01%	411
2017 Q3	$7K	Buy	+116	New	+$12.5K	﹤0.01%	378

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Alpha Omega Wealth Management's ICPT Position: Q3 2019 in Review

Alpha Omega Wealth Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2019, closing a stake of 140 shares — an estimated $11K sold.

Alpha Omega Wealth Management first reported a position in ICPT in Q3 2017 and held it in 8 quarters. The position peaked at $18K in Q3 2018. 188 funds tracked by Wall St. Rank hold ICPT as of Q3 2019.

Alpha Omega Wealth Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Alpha Omega Wealth Management sold 140 Intercept Pharmaceuticals, Inc. shares in Q3 2019, an estimated $11K.
Alpha Omega Wealth Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2017 and held it in 8 quarters.
Alpha Omega Wealth Management's Intercept Pharmaceuticals, Inc. position peaked at $18K in Q3 2018.
188 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.